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Objective: Vitamin D has been widely studied as a mediator of the immune response, becom-
ing  evident the prevalence of hypovitaminosis D in patients with Crohn’s disease. This work
aims at evaluating the serum levels of vitamin D in patients suffering from Crohn’s disease
in  a southeast region of Brazil.
Methods: It is a prospective study, with statistical analysis of the values of serum vitamin
D  measured between April 2014 and April 2015 in patients with Crohn’s disease. Individ-
uals with mild anal complaints, without any colorectal involvement, comprised the control
group.
Results: One hundred and four patients whose average age was 40.6 years were evalu-
ated, being 56 (53.8%) female and 48 (46.2%) male. The average serum vitamin D level was
21.6  ng/mL, with standard deviation 13.85. The control group was comprised by 66 indi-
viduals, whose average age was 48.9 years. With 38 (57.6%) female and 28 (42.4%) male. In
this  group the average serum vitamin D level was 40.9 ng/mL. Statistical signiﬁcance was
demonstrated with p < 0.0001.
Conclusion: There was high prevalence of hypovitaminosis D in patients with Chron’s dis-
ease, when compared to the control group. Hypovitaminosis D was not evidenced in patients
in  the latter group.©  2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/). Part of this study was presented as “Oral Presentation in the Brazilian Congress of Coloproctology”, in September 2014 at Brasília, DF,
razil;  and in September 2015 at Rio de Janeiro, RJ, Brazil.
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E-mails: proctologia@hospitaldebase.com.br, priscillacreboucas@gmail.com (P.C. Rebouc¸as).
ttp://dx.doi.org/10.1016/j.jcol.2016.03.001
237-9363/© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
Y-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Hipovitaminose  D  em  pacientes  portadores  da  doenc¸a de  Crohn
Palavras-chave:
Doenc¸a de Crohn
Doenc¸a inﬂamatória intestinal
Vitamina D sérica
25(OH)D
r  e  s  u  m  o
Objetivo: A vitamina D tem sido amplamente estudada como mediadora da resposta imune,
tornando-se evidente a prevalência de hipovitaminose D em pacientes com doenc¸a de
Crohn. Este trabalho objetiva avaliar os níveis séricos de vitamina D nos pacientes com
portadores de doenc¸a de Crohn em uma região do sudeste do Brasil.
Métodos: Trata-se de estudo prospectivo, com análise estatística dos valores da vitamina
D  sérica dosados entre Abril de 2014 e Abril de 2015 em pacientes com doenc¸a de Crohn.
Indivíduos com queixas anais leves, sem qualquer acometimento colorretal, compuseram
o  grupo controle.
Resultados: Foram avaliados 104 pacientes, cuja média de idade foi de 40,6 anos, sendo 56
(53,8%) mulheres e 48 (46,2%) homens. O nível sérico de vitamina D médio foi 21,6 ng/mL,
com  desvio-padrão de 13,85. O grupo controle foi composto por 66 indivíduos, cuja média
de  idade foi 48,9 anos, com 38 (57,6%) mulheres e 28 (42,4%) homens. Neste grupo o nível
sérico  médio de vitamina D foi 40,9 ng/mL. Foi demonstrada signiﬁcância estatística com
p  < 0,0001.
Conclusão: Houve elevada prevalência de hipovitaminose D em pacientes com doenc¸a de
Crohn, quando comparados ao grupo controle. Não foi evidenciada hipovitaminose D entre
os  pacientes deste último grupo.
© 2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este
é  um artigo Open Access sob a licença de CC BY-NC-ND
toward the investigation of the relationship between vitamin
D and Crohn’s disease in the scenario of southern tropi-
cal countries, being able to, in the future, cooperate for the
Table 1 – Clinical interpretation of serum vitamin D
levels.1–3
Serum vitamin D levels (ng/mL) Clinical interpretation
≤10 Severe hypovitaminosis
11–20 Vitamin D deﬁciency
21–29 Vitamin D insufﬁciency
30–36 Vitamin D adequate valuesIntroduction
Crohn’s disease is an intestinal inﬂammatory disease char-
acterized by chronic intestinal inﬂammation of autoimmune
character and uncertain etiology.1–7 However, there is proven
importance of the interaction between genetic and envi-
ronmental factors in the triggering of the aberrant cellular
immune response through Th1, Th17 cells and their pro
inﬂammatory cytokines.1–3,7–11
In the context of cellular immunity, the discovery of the
presence of vitamin D receptor (VDR) in the macrophages and
lymphocytes, has opened a new path for research concerning
autoimmune diseases.1–3,7–13
Vitamin D is a steroid hormone derived from cholesterol,
obtained, mainly through solar exposition to beta-ultraviolet
rays.1,7–12 However, there is also a small acquisition from
dietary intake.1,7–9,11 This steroid is metabolized in the liver
and subsequently in the epithelium of the renal proximal
tube in its active form, the calcitriol (1,25OH2D). It has been
evidenced that the serum vitamin D, in most part of it (85–90%)
carried by the vitamin D carrier protein (DCP), has a signif-
icant role in the cellular immune response.1 By diffusion,
the vitamin D enters in the defense cells and is activated by
1-hydroxylase in 1.25(OH)2D3 (Vitamin D3) and 1.25(OH)2D
(Vitamin D2).1 They form a complex when linked to the
vitamin D receptor which activates the gene transcription,
which act on the cellular immune response through the
inhibition of T cells.1,3,9–11 Suppressed, the Th1 and Th17
cells, determine the reduction of production and release of
their pro-inﬂammatory cytokines, such as IFN, IL2, IL12 and
IL17.1,3,9–12
Besides the inhibitory effect to these cells, the activated
DCP complex, also stimulates the proliferation of T-regulatory(http://creativecommons.org/licenses/by-nc-nd/4.0/).
cells (T-reg), regaining then, the gastrointestinal immunologi-
cal homeostasis.1,3,9–11
When evaluated the role of vitamin D in innate immu-
nity, it has been found that the activation of the receptors
of the membrane tool-like receptors (TLR) of macrophage by
intestinal bacteria result in the conversion and bioavailabil-
ity of active vitamin D, besides the increase of the expression
of DCP and antimicrobian peptides, such as cathelicidins and
defensins.1,3,9,11
The classiﬁcation of serum vitamin D concentration ranges
from severe deﬁciency to toxic levels, according to reference
values, as demonstrated in Table 1.1,2,8
Several studies have demonstrated the prevalence of
hypovitaminosis D in patients suffering from Crohn’s
disease.2,4–6,8,14–17 In this context, data, still uncertain, show
interference of serum vitamin D low levels in the appearance
and progression of the disease.2,3,9–11,18,19
Aiming at carrying out data surveying, as the ﬁrst step≥60 Above limit values
100–150 Toxic values
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Table 2 – Characteristics of groups concerning age and
gender.
Characteristics Crohn’s disease Control
N 104 66
Age – Average (SD) 40.6 (14.01) 48.9 (13.97)
Gender
Female (%) 56 (53.8%) 38 (57.6%)
Male (%) 48 (46.2%) 28 (42.4%)
18%
7%
32%
28%
15%
Severe hypovitaminosis (≤10) Vitamin D deficiency
Vitamin D insufficiency Vitamin D adequate values (30-36)
Values between 37-59
Fig. 1 – Serum vitamin D levels in patients with Crohn’sj coloproctol (rio j
eveloping of new tools to evaluate disease activity and even
he treatment optimization, this study has as aim to evaluate
erum vitamin D levels in patients suffering from Crohn’s dis-
ase followed by the Discipline of Coloproctology of Hospital
e Base in São José do Rio Preto/SP (FAMERP), comparing them
o a control group.
ethods
t is about a transversal study, carried out in São José do Rio
reto, a city located in the southeast region of Brazil, latitude
0◦49′11′′ South, 489 m above the sea level.
Patients suffering from Crohn’s disease were identiﬁed,
ith clinical, endoscopical and histopatological diagnosis, fol-
owed by the Coloproctology discipline of Hospital de Base de
ão José do Rio Preto/SP, of the Medical School of São José do
io Preto, and afterwards, made a database with the serum
itamin D values dosed between April 2014 and April 2015,
heir age and gender. Similar data, in the same period, were
ollected from individuals with mild anal complaints, with
o colorectal involvement, also assisted by the same medical
eam, comprising thus, the control group.
Serum vitamin D dosage was carried out by laboratorial
xams, requested during the patients’ follow up in the out-
atient clinic. All the exams were carried out by the Central
aboratory of Hospital de Base of São José do Rio Preto/SP
hrough electrochemiluminescense, considering insufﬁcient
evels of vitamin D, values lower than 30 ng/mL, according to
ata from the US National Kidney Foundation.
The data were submitted to descriptive statistical analy-
is, with values of media, median and standard deviation, and
omparative analysis through Mann–Whitney non-parametric
est, being considered statistical signiﬁcance for values of
 > 0.05.
thical  considerations
he study was approved by the Research Ethics Commit-
ee of the Medical School of São José do Rio Preto (CAAE:
1070614.7.0000.5415), and informed written consent was
btained from each subject before entering the study.
esults
ne hundred and four patients suffering from Crohn’s disease
ere evaluated, whose average age was 40.6 years (SD 14.01),
anging from 15 to 75 years, being 56 (53.8%) female and 48
46.2%) male. Among the individuals that comprised the con-
rol group, in a total of 66, the average age was 48.9 years (SD
3.97), ranging from 15 to 79 years, being 38 (57.6%) female and
8 (42.4%) male (Table 2).
The average serum vitamin D level among patients with
D, was 21.6 ng/mL, with SD of 13.85, ranging from 3.0 to
8.3 ng/mL. Fifty nine patients were identiﬁed with hypovi-
aminosis D, representing 66.3%. From these, seven (6.7%)
resented serum vitamin D values lower or equal 10 ng/mL,
hirty three (31.7%) between 11 and 20 ng/mL and twenty nine
27.9%) between 21 and 29 ng/mL. Only 16 (15.4%) presenteddisease.
serum vitamin D value within adequate values, between 30
and 36 ng/mL (Fig. 1).
Among the control group’s individuals, the serum vitamin
D level was 40.9 ng/mL, with SD of 15.54. Serum vitamin D val-
ues considered adequate or above normality were presented
by 52 patients (78.8%).
According to the comparative analysis between serum vita-
min  D values of both groups, through the Mann–Whitney test,
p value was lower than 0.0001 (Table 3).
Discussion
Epidemiologically, the literature data corroborate with the
present study. The literature shows bimodal incidence of
Crohn’s disease in relation to age, affecting individuals from
15 to 40 years, and from 50 to 80 years.2,4,5,8,14,17,20 There is
also, agreement on the involvement between gender, with a
2,8,14,17 8higher percentage of women. De Bruyn et al. evalu-
ated the vitamin D deﬁciency in 101 patients suffering from
Crohn’s disease, with average age of 41 years and mostly
females. Similar epidemiological ﬁnding was demonstrated by
62  j coloproctol (rio j). 2 
Table 3 – Comparative analysis of serum vitamin D
levels between groups.
Serum vitamin D (ng/mL) Crohn’s disease
(n = 104)
Control group
(n = 66)
Average (SD) 21.626 (13.851) 40.950 (15.541)
Values
Minimum 3.0 8.2
Maximum 58.3 105.0
Median 21.650 39.650
Conﬁdence interval 18.929–24.323 37.127–44.773
r
1
1
1
1Statistical signiﬁcance (p) <0.0001
Ananthakrishnan et al.17 and Azzopardi et al.20 The charac-
teristics between groups, patients with Crohn’s disease and
control group were similar.
The serum vitamin D level dosing of patients with Crohn’s
disease corroborated the ﬁndings of the great majority of
studies already published, demonstrating the prevalence of
hypovitaminosis D. The average serum vitamin D among the
patients with Crohn’s disease ranged, in the literature from
13.1 to 27 ng/mL2,4–6,8,14,17 Yet, the control group presented
serum vitamin D levels considered adequate.
The comparative analysis between the patients and the
control group demonstrated high statistical signiﬁcance, in
agreement with data presented in the literature. Studies with
such emphasis have been disclosed, mainly, from 2013, how-
ever up to now there have not been data concerning countries
with a tropical climate in the southern hemisphere.
The hypovitaminosis D is common in high latitude
regions.1,2,4,5,8,18,20 Brazil is located in a low latitude area
in the southern hemisphere, close to the tropics, showing
favorable geographic position and high incidence of ultravi-
olet radiation. However, the present study obtained similar
results to those found in countries located in high latitudes,
demonstrating, thus, the presence of hypovitaminosis D in
patients suffering from Crohn’s disease, contrary to serum
levels presented by the control group, being them, the very
representatives of the country’s geographic position. De Bruyn
et al.8 study, carried out in Holand, showed the presence of
hypovitaminosis D among patients suffering from Crohn’s
disease, as well as Dumitrescu et al.4 study, carried out in
Romenia.
The serum vitamin D dosing of this study, for both groups,
took place during a whole year, involving all the seasons of
the year, different levels of UV rays incidence and degrees
of solar exposition, however, a better control of homogene-
ity in the collecting must be done in order to reduce possible
biases. A study published by Raftery et al.19 shows rela-
tionship between vitamin D and activity of Crohn’s disease
irrespectively of the season of the year. Therefore, hypovi-
taminosis D has presented itself prevalent in this group of
patients, irrespectively of the region of the world or time of the
year.
ConclusionIn conclusion, the prevalence of low serum vitamin D levels
has been evidenced among patients suffering from Crohn’s
10 1 6;3  6(2):59–63
disease followed by the service of Coloproctology of Hospi-
tal de Base in São José do Rio Preto/SP, when compared to a
control group, group which presented serum levels considered
satisfactory.
The issue, however, still needs more  comprehensive stud-
ies, mainly those who aim at evaluating serum vitamin
D values related to clinical treatment and also the effects
of vitamin D supplementation in the activity of the dis-
ease and healing of the mucous membrane. Thus, it will
possible to evaluate in a relevant way, the vitamin D repo-
sition in the Crohn’s disease remission, optimizing these
patientst´reatment and corroborating for the improvement of
their quality of life.
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